Documenten
ESG Charter Aescap January 14, 2022
Self-certification form individuals (FATCA)
Self-certification form entities (FATCA)
Aescap Life Sciences
2021 ESG Engagement Report Aescap Life Sciences
Prospectus Aescap Life Sciences
Explanation amendments Prospectus Aescap Life Sciences
Supplement I to Prospectus Aescap Life Sciences
Explanation Supplement I to Prospectus Aescap Life Sciences
Subscription Form
Additional Subscription Form
Redemption form
Statement regarding Sustainable Finance Disclosure Regulation
Aescap Genetics
Prospectus Aescap Genetics
Subscription Form
Additional Subscription Form
Statement regarding Sustainable Finance Disclosure Regulation
Fund Manager
Semi-Annual Report 2022
Annual Report 2021
Semi-Annual Report 2021
Annual Report 2020
Semi-Annual Report 2020
Annual Report 2019
Semi-Annual Report 2019
Annual Report 2018
Semi-Annual Report 2018
Annual Report 2017
Semi-Annual Report 2017
Annual Report 2016
Semi-Annual Report 2016
Annual Report 2015
Semi-Annual Report 2015
Annual Report 2014
Annual Report 2013
Annual Report 2012
Aescap Life Sciences – Key Investor Document / Essentiële Beleggersinformatie
KID – Investors Unit Class
KID – Investors €10M+ Unit Class
KID – Investors €20M+ Unit Class
KID – Investors €30M+ Unit Class
KID – Investors UK Unit Class
KID – Investors <500k Unit Class
KID – Investors Manager Unit Class
Key Information Investor Document Unit Class Aescap Life Sciences – Investors (NL)
Key Information Investor Document Unit Class Aescap Life Sciences – Investors < 500k (NL)
Aescap Genetics – Key Investor Document / Essentiële Beleggersinformatie
KID – Investors Unit Class
KID – Investors €10M+ Unit Class
KID – Investors €20M+ Unit Class
KID – Investors €30M+ Unit Class
KID – Investors Manager Unit Class
EBI Aescap Genetics Investors (NL)
Financial Reports Aescap Life Sciences
